Patent directory · USPTO A61K / A61P
Patents matching “The Regents of the University of California”
3,494 pharma patents match "The Regents of the University of California" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 3,494 pharmaceutical patents matching "The Regents of the University of California" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 6569664
Native TNF receptor releasing enzyme
expired -
US 6566324
Preventing airway mucus production by administration of EGF-R antagonists
expired -
US 6565889
Bilayer structure which encapsulates multiple containment units and uses thereof
expired -
US 6566342
Gene therapy by secretory gland expression
expired -
US 6566326
Chemically modified hemoglobin for burn shock resuscitation
expired -
US 6562819
Compounds for inhibition of ceramide-mediated signal transduction
expired -
US 6562606
Methods and compositions for disrupting the epithelial barrier function
expired -
US 6558668
Methods for detection and treatment of neural cancers
expired -
US 6555582
Eye treatments using synthetic thyroid hormone compositions
expired -
US 6555347
Human minor vault protein p193
expired -
US 6555116
Alleviation of the allergenic potential of airborne and contact allergens by thioredoxin
expired -
US 6551588
Tumor radiosensitization using gene therapy
expired -
US 6551989
Preventing airway mucus production by administration of EGF-R antagonists
expired -
US 6548521
Inhibitors of metazoan parasite proteases
expired -
US 6548679
Antitumor agents
expired -
US 6544956
Lunasin peptides
expired -
US 6544757
Synthesis of human virus antigens by yeast
expired -
US 6545034
Use of etodolac for the treatment of chronic lymphocytic leukemia
expired -
US 6541212
Methods for detecting prostate stem cell antigen protein
expired -
US 6541195
Correction of genetic defects using chemical chaperones
expired -
US 6537768
Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC panca antigens
expired -
US 6534062
Methods for increasing a cytotoxic T lymphocyte response in vivo
expired -
US 6534283
Method for treatment and prevention of physiological shock
expired -
US 6534310
Suppression of proteolytic activity by dysfunctional protease formation
expired